ELI LILLY AND COMPANY ALERT: Bragar Eagel & Squire, P.C. is Investigating Eli Lilly and Company on Behalf of Eli Lilly Stockholders and Encourages Investors to Contact the Firm
October 15, 2020 20:00 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Eli Lilly and Company...
Global Rheumatoid Arthritis Therapeutics Market; High adoption of disease-modifying antirheumatic drugs (DMARDs) will boost the market - PMI
June 25, 2020 10:35 ET
|
PMI
Covina, CA, June 25, 2020 (GLOBE NEWSWIRE) -- The global rheumatoid arthritis therapeutics market accounted for US$ 25.7 billion in 2019 and is estimated to be US$ 39.8 billion by 2029 and is...
World-Renowned Oncologist Bullish on Potential of PharmaCyte’s Technology, Clinical Trial in Pancreatic Cancer
January 23, 2019 09:25 ET
|
PharmaCyte Biotech
NEW YORK, NY, Jan. 23, 2019 (GLOBE NEWSWIRE) -- With PharmaCyte Biotech, Inc.’s (OTCQB: PMCB) naming of Medpace, Inc., a global full-service clinical contract research organization (CRO) to conduct...
Endocrinologist & Researcher Dr. Dara P. Schuster Named CEO of T1D Exchange
June 22, 2018 08:00 ET
|
T1D Exchange
BOSTON, June 22, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a patient-centered research organization dedicated to accelerating therapies and improving care for people with type 1 diabetes (T1D), today...
CORRECTING and REPLACING – Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge
May 22, 2018 10:10 ET
|
T1D Exchange
In a release issued under the same headline earlier today by T1D Exchange please note that in the third paragraph of the release the name of the Protomer Technologies Founder and CEO should by Alborz...
Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge
May 22, 2018 07:00 ET
|
T1D Exchange
BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- Protomer Technologies of Pasadena, CA, will receive $50,000 in cash and up to $150,000 of in-kind support as the winner of the 2018 Diabetes Innovation...
PharmaCyte Closing in on Submission of Crucial Investigational New Drug Application to Begin Clinical Trial in Pancreatic Cancer
May 21, 2018 09:20 ET
|
PharmaCyte Biotech
NEW YORK, NY, May 21, 2018 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) has reached the proverbial “home stretch” regarding its efforts to submit an Investigational New Drug Application...
Media Advisory: Monday, May 21 - 2018 Diabetes Innovation Challenge Pitch Off
May 16, 2018 09:00 ET
|
T1D Exchange
ROYAL SONESTA BOSTON3:00 PM – 5:00 PM $250,000 IN CASH AND IN-KIND PRIZES TO BE AWARDED BOSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Ten finalists, all academic researchers and early stage companies,...
Finalists Announced for 2018 Diabetes Innovation Challenge
April 24, 2018 08:10 ET
|
T1D Exchange
BOSTON, April 24, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit patient-centered research organization dedicated to accelerating novel treatments to improve the lives of people with type 1...
INVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKS
December 13, 2017 13:13 ET
|
Azzad Funds
Falls Church, Dec. 13, 2017 (GLOBE NEWSWIRE) -- SOURCE - AZZAD ASSET MANAGEMENT Investors today announced they have filed resolutions at five major pharmaceutical companies asking for information...